0001708138-20-000113.txt : 20201211
0001708138-20-000113.hdr.sgml : 20201211
20201211160525
ACCESSION NUMBER: 0001708138-20-000113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201209
FILED AS OF DATE: 20201211
DATE AS OF CHANGE: 20201211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fenimore Christopher R.
CENTRAL INDEX KEY: 0001697422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 201383620
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-12-09
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001697422
Fenimore Christopher R.
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
VP Controller
Common Stock
2020-12-09
4
A
0
969
0.0
A
19352
D
Common Stock
2020-12-09
4
A
0
1750
0.0
A
21102
D
Common Stock
2020-09-24
5
G
0
50
0.0
D
0
I
by 2017 GRAT
Common Stock
2020-09-24
5
G
0
25
0.0
A
25
I
by Trust for Daugh
Common Stock
2020-09-24
5
G
0
25
0.0
A
25
I
by Trust for Son
Common Stock
1432
I
By 401(k) Plan
Common Stock
1897
I
By Trust
Common Stock
1861
I
by 2018 GRAT
Non-Qualified Stock Option (right to buy)
492.0
2020-12-09
4
A
0
10000
0.0
A
2030-12-09
Common Stock
10000
10000
D
Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 9, 2022 and 50% on December 9, 2024.
Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 9, 2024.
These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Christopher R. Fenimore
2020-12-10